Genetic variants in IRF5 that reduce its expression are associated with decreased susceptibility to UC [10] and other immune-mediated diseases, such as systemic lupus erythematosus (SLE) [11,12], rheumatoid arthritis, and primary biliary cirrhosis [13,14]. Here, IRF5 is linked to systemic lupus erythematosus.